PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
55.22
ESG score 90-95% of KOD's 60.45. Bill Ackman would demand clear ESG improvement catalysts.
51.62
Environmental score 80-90% of KOD's 58.62. Walter Schloss would scrutinize carbon exposure and transition planning.
56.90
Social score 90-95% of KOD's 60.23. Bill Ackman would demand clear social improvement catalysts.
57.14
Governance score 90-95% of KOD's 62.50. Bill Ackman would demand clear governance improvement catalysts.